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Abstract
Sequence variants in the first intron of FTO are strongly associated with human obesity and human carriers of the risk alleles
show evidence for increased appetite and food intake. Mice globally lacking Fto display a complex phenotype characterised
by both increased energy expenditure and increased food intake. The site of action of FTO on energy balance is unclear.
Fasting reduces levels of Fto mRNA in the arcuate nucleus (ARC) of the hypothalamus, a site where Fto expression is
particularly high. In this study, we have extended this nutritional link by demonstrating that consumption of a high fat diet
(45%) results in a 2.5 fold increase in Arc Fto expression. We have further explored the role of hypothalamic Fto in the
control of food intake by using stereotactic injections coupled with AAV technology to bi-directionally modulate Fto
expression. An over expression of Fto protein by 2.5-fold in the ARC results in a 14% decrease in average daily food intake in
the first week. In contrast, knocking down Arc Fto expression by 40% increases food intake by 16%. mRNA levels of Agrp,
Pomc and Npy, ARC-expressed genes classically associated with the control of food intake, were not affected by the
manipulation of Fto expression. However, over expression of Fto resulted in a 4-fold increase in the mRNA levels of Stat3, a
signalling molecule critical for leptin receptor signalling, suggesting a possible candidate for the mediation of Fto’s actions.
These data provide further support for the notion that FTO itself can influence key components of energy balance, and is
therefore a strong candidate for the mediation of the robust association between FTO intronic variants and adiposity.
Importantly, this provide the first indication that selective alteration of FTO levels in the hypothalamus can influence food
intake, a finding consistent with the reported effects of FTO alleles on appetite and food intake in man.
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Introduction
Mutations leading to highly penetrant forms of human obesity
frequently disrupt the central control of appetite and lead to
increased food intake [1]. It will be important to establish whether
common polymorphisms associated with obesity act similarly.
Common variants within intron 1 of the fat mass and obesity
associated gene (FTO) are strongly and consistently associated with
human adiposity [2,3]. Ten subsequent studies have examined the
influence of FTO variants on measures of appetite, food intake or
energy expenditure [4–13]. While the obesity risk alleles are not
associated with reduced energy expenditure, nine of these studies
reported an association with increased appetite or measured ad
libitum food intake [4,6–13]. As yet, there is no evidence that the
risk alleles influence FTO expression and the variants could
conceivably influence adiposity through effects on more distant
genes. The global ablation of Fto expression in mice [14] results in
high early mortality but the surviving mice are small, with reduced
lean and fat mass. The absolute food intake of Fto +/+ and Fto2/2
mice is identical but when corrected for lean mass, Fto2/2 have an
increased food intake. Similarly Fto 2/2 mice have increased
oxygen consumption when corrected for lean mass. More recent
findings reported in a mouse with a missense loss of function ENU
induced mutation in Fto [15] strongly suggest that FTO is likely to be
involved in the control of energy balance.
FTO is widely expressed across multiple tissues, but is most
highly expressed in brain and especially the hypothalamus [2,16].
We have previously shown that murine Fto mRNA levels are
decreased by fasting and increased by feeding in the arcuate
nucleus (ARC) of the hypothalamus [16]. In this study, we have
extended this observation by demonstrating that consumption of a
high fat diet results in an increase in ARC Fto expression. We then
examined whether manipulating Fto levels in the ARC might have
any effects on spontaneous food intake in rats. In parallel, we
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8771
examined the effects of manipulating Fto levels in the nearby
paraventricular nucleus (PVN), a site known to be important for
the control of energy balance but where Fto expression was not
altered by nutritional state [16]. We demonstrate that manipula-
tion of Fto expression in the arcuate nucleus bi-directionally
influences acute food intake in rats, implicating the brain and
specifically the ARC in mediating at least some of the effects of
FTO on energy balance.
Results
Endogenous Fto Expression in the ARC
We have previously reported that Fto expression in the ARC is
decreased with nutritional deprivation. We examined the effect of
high fat feeding on the expression of Fto in hypothalamic nuclei.
After 10 weeks of exposure to a high fat (45%) diet, body weight
(HFD 549.5622.6g vs. chow 426.8633.3g; p= 0.01) and fat mass
(retroperitoneal fat: HFD 1.360.2 vs. chow 0.760.1% of body
weight; p = 0.03) were significantly increased in the high fat fed
group without an increase in energy intake (HFD 9963.7 vs. chow
10662.7Kcal). These physiological changes was accompanied by
an increase in the Fto mRNA levels in the ARC by 2.5 fold
compared to rats provided with regular chow (Fig 1A). In order to
determine whether Fto is co-expressed with any specific ARC
neuronal population, we performed co-localisation studies of Fto
with the classical ARC expressed anorexigenic pro-opiomelano-
cortin (Pomc) using double in situ hybridisation. We confirmed
abundant expression of Fto in the ARC, and although its expression
overlaps with that of Pomc (Fig 1B), Fto appears to be diffusely
expressed throughout the ARC and is therefore likely to be present
in many neuronal and non-neuronal populations. Thus, rather than
manipulating Fto expression in specific ARC neuronal populations,
Figure 1. Endogenous Fto expression in the ARC. (A) Fto expression, quantified by real-time RT-PCR, is up-regulated in the arcuate nucleus
following a high-fat diet demonstrated by the relative arcuate Fto mRNA expression in rat either fed on a standard chow or on a high-fat diet for 10
weeks. Data is represented as the mean6S.E.M of at least 6 independent rats per group; **P,0.01. (B) Fto mRNA is diffusely expressed throughout
the arcuate nucleus and overlaps with Pomc neurons. Double in situ hybridization detecting Fto (35S labeled) and Pomc (DIG labeled) mRNA in the
cells of the arcuate nucleus. Insert in figure shows a high-magnification (scale bar, 20 mm) of a Pomc containing neurons colocalised with Fto (marked
with *). (C) Intra-nuclei bilateral injections of adeno-associated virus (AAV2/7) mediated transfer of GFP cDNA precisely targets the hypothalamic
arcuate (ARC) and paraventricular (PVN) nuclei; as demonstrated by photomicrographs of representative coronal sections showing localization of GFP
7 days after injection; right panels, higher magnification of area indicated by red box. Scale bar, 100mm. 3v: third ventricle; ME: median eminence.
doi:10.1371/journal.pone.0008771.g001
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we chose a strategy employing AAVmediated transfer of Fto cDNA
and shRNA coupled with stereotactic injection in order to
manipulate Fto expression within the ARC (Fig 1C).
Manipulation of Fto Expression within the ARC and PVN
In order to determine the optimum AAV serotype and titre, as
well as to confirm the accuracy of intranuclear injections, AAV-2/
5,2/7,2/8 and 2/9 with GFP were initially produced. AAV-2/7
provided most effective and specific transduction for the
hypothalamic nuclei (Fig 1C) and the time course for GFP
expression was similar to that reported for other AAV serotypes
reported such that the protein was expressed by day 3 following
injection and lasted for at least 2 months. Thus all the
experimental AAVs used for the following studies were generated
using serotype 2/7.
To modulate Fto expression levels in the ARC and PVN, we
generated four AAV 2/7vectors: i.) AAV mediated transfer of full
length Fto cDNA was used for overexpression; ii.) shRNA targeting
Fto mRNA for knockdown of gene expression and iii.) two different
AAV-controls (empty vector for AAV-Fto and containing a
scrambled shRNA sequence for AAV-shRNA). The rat Fto specific
shRNA that we generated effectively inhibited the expression of
endogenous Fto in hypothalamic GT1-7 cells by 90%, whereas
transfection with scrambled control did not affect the production
of the Fto protein (Fig 2A).
2061012 vg/ml of AAV-Fto, AAV-shRNA and their respective
controls were stereotactically injected bilaterally to transduce
either the ARC or PVN (Fig 1C) of rats. To assess the specificity of
AAV delivery, at the end of the study, 3 weeks after AAV
injections, micro-punches from both the ARC or PVN were
obtained for all experimental animal and tested for changes in Fto
expression using real-time quantitative RT-PCR (Fig 2B). From
the same dissections, protein expression was measured by semi-
quantitative western blotting analysis (Fig 2C). For the over
expression studies, at the protein level, we achieved approximately
2.5 fold increase in total Fto levels in the ARC and a 1.5 fold
increase in the PVN. Whilst for the knockdown experiments, Fto
expression was decreased by 40% in both the ARC and the PVN
compared to rats injected with scrambled AAV.
Effects of AAV-Fto and AAV-shRNA Microinjection in
Hypothalamic ARC
We investigated the effect of Fto on feeding behaviour in rats. At
the end of the experiment, we check for Fto expression as an
indication for correct site of injection. Three animals (2 from the
ARC study and 1 from the PVN study) were excluded from further
analysis as expression of both Fto RNA and protein levels in these
animals were not altered at least 5% as compared to controls.
Over expression of Fto in the ARC resulted in a decrease in food
intake, compared to rats injected with empty vector (Fig 3A, B).
Conversely, a 40% reduction in Fto protein expression resulted in
an increase in food intake (Fig 3C, D). Expressing the data as
average daily food intake, the peak of the effect was reached within
the first week: 14% reduction in the Fto over expressing group and
16% increase in food intake with knockdown (Fig 3E). However,
despite having an impact on food intake, there was no significant
difference between the body weight of rats that received injection
of the AAV-Fto and AAV-shRNA with respective controls (Fig 3G,
H). There was also no significant difference in fat mass (Fig 3F).
Effects of AAV-Fto and AAV-shRNA Microinjection PVN
As a comparator, we also perturbed expression of Fto in the
PVN. Interestingly, although over-expression of Fto in the PVN
also resulted in a reduction of food intake (Fig 4A, B, D), a similar
degree of Fto knockdown in the PVN had no effect on food intake
(Fig 4C, 4D).
Effects of Manipulating ARC Fto on Genes Involved in
Energy Homeostasis
Using real-time quantitative RT-PCR we determined that the
ARC-expressed genes classically associated with the control of
food intake, namely, Agrp, NPY and Pomc were not affected by
altered Fto expression (Fig 5). However, a 4-fold increase in the
expression of the transcription factor Stat3, and a 5- fold reduction
in Tyrosine Hydroxylase, was observed with Fto over expression in
the ARC, suggest possible candidates for the mediation of Fto’s
action.
Discussion
Previously, we have demonstrated that Fto is highly expressed in
hypothalamic nuclei critical for regulating energy homeostasis,
and that its expression within the ARC is reduced following a 48hr
fast. Here we report that a high fat diet results in an increase of
ARC Fto expression, demonstrating that Fto levels can be bi-
directionally regulated depending on nutritional status. Due to the
diffuse nature of Fto expression within the ARC, we chose to
manipulate Fto expression throughout the nuclei resulting in a
bidirectional impact on food intake.
Lack of FTO from conception, in both humans [17] and mice
[14], results in severe growth retardation and high levels of early
mortality, accompanied in humans, but not mice, by multiple
developmental anomalies. We have reported that FTO is a
nuclear-localised 2-oxoglutarate and Fe2+ dependent dioxygenase
which is capable of demethylating 3-methyl thymine in nucleic
acids [16] and that heterozygous, loss-of-function mutations in
human FTO exist but are found in both lean and obese subjects
[18]. Thus, FTO’s true, physiological substrate(s) and function
remains unclear.
However, evidence up-to-date suggests that the FTO variant
confers a predisposition to obesity to be involved in the regulation
of food intake rather than in the regulation of energy expenditure.
As of the ten studies examining the influence of FTO variants,
except for one based on questionnaires [5], all others reported an
association with increased appetite whist three studies on energy
expenditure showed no effects [4,6,8]. Despite this, the effects of
global reduction in Fto function on energy homeostasis in mice are
complex with Fto null and hypomorphic mice having low adipose
stores with increased energy expenditure. Our findings demon-
strate that reduction in Fto expression selectively in the ARC
results in increased food intake, a finding consistent with the
hyperphagia seen in mice lacking Fto and congruent with the fact
that fasting (a strong stimulus to eating) reduces Fto mRNA levels
in the ARC [16]. Over-expression of Fto in either ARC or PVN
caused a reciprocal reduction in food intake. Our paradigm of
stereotactic injection of AAV into the ARC or PVN does not
permit correlations between physiological end points and levels of
gene expression, because only a subset of the total neurons within
each nuclei were infected. However, it is noteworthy that
reduction in Fto expression in only a limited number of ARC
cells is sufficient to affect food intake.
mRNA levels of Agrp, Pomc and Npy, ARC-expressed genes
classically associated with the control of food intake, were not
affected by the manipulation of Fto expression. However, over
expression of Fto resulted in a 4-fold increase in the mRNA levels
of Stat3, suggesting a possible candidate for the mediation of Fto’s
actions within the ARC. Stat3 is a ubiquitous transcription factor
Hypothalamic Fto
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Figure 2. Manipulation of Fto expression within the ARC and PVN. (A) Knockdown of Fto in GT1-7 cells. Fto short hairpin RNA expressed
from U6 promoter were transfected into cultured hypothalamic GT1-7 cells resulting in efficient knockdown of Fto mRNA (quantified by real time RT-
PCR, left panel) and protein (western blot analysis, right panel) compare with cells transfected with scramble shRNA sequence. (B–C) Confirmation of
AAV mediated transfer of full length cDNA (AAV-Fto) for over expression and shRNA (AAV-shRNA) for knockdown of Fto 3 weeks following intra-
nuclei injection. Fto expression is increased by AAV-Fto and decreased by AAV-shRNA as compared to controls (empty vector for AAV-Fto and
scrambled sequence for AAV-shRNA). Bar graphs show the quantified change in expression of Fto. Response is expressed in terms of fold induction
over the control. (B) Fto mRNA relative to expression of B-actin was determined by real-time quantitative PCR. Left panel shows representative
amplification curve from PVN micro-punches of AAV-Fto and AAV-shRNA injected rats. (C) Fto protein levels were measured by semi-quantitative
western blot analysis. Left panel shows representative blots from micro-punched AAV-shRNA injected ARC and from AAV-Fto injected PVN. Western
blots were probed with mouse monoclonal antibodies directed against the C-terminal Fto. B-actin was used as a loading control and bands were
visualized and semi-quantified using Chemiluminescence. P-value was calculated using a two-tailed distribution unpaired Student’s t-test. Data is
represented as the mean 6S.E.M of at least 6 independent rats per group. *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0008771.g002
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Figure 3. Effects of AAV-shRNA and AAV-Fto microinjection in hypothalamic ARC. Effects of manipulating Fto expression in rat
hypothalamic ARC. The 2-way repeated measures ANOVA indicated that ARC injection of (A) AAV-Fto significantly reduces daily food intake
(F1,140 = 15.28; p = 0.002) and (B) 2 weeks cumulative food intake (F1,140 = 13.26; p = 0.003). Whilst (C,D) AAV-shRNA had a significant effect on
induction of food intake (daily: F1,140 = 8.823; p = 0.01; cumulative: F1,140 = 13.73; p = 0.002). (E) Significant effects of Fto over expression on food intake
last for 2 weeks whilst the effect of Fto knockdown was only significant in the first week. All values are expressed as mean6S.E.M. Statistical
comparison between control and treated groups for each site were performed by two-tailed unpaired Student’s t-test; **p,0.01.There were no
significant effects of ARC Fto over expression and knockdown on (F) fat mass normalized to final body weight or (G–H) body weight gain expressed
as percentage change from pre-surgical weight.
doi:10.1371/journal.pone.0008771.g003
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PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8771
that is indispensable during early embryogenesis. In adult tissue, in
addition to its critical role in leptin receptor signalling [19], Stat3
has also been shown to play crucial roles in a variety of biological
functions including cell growth, apoptosis and cell motility [20].
The increase in Stat3 expression associated with overexpression of
Fto and reduced food intake is consistent with its potential role in
mediating leptin’s anorectic effects. Tyrosine hydroxylase (TH)
expression in the ARC was inversely modulated by Fto. It is
tempting to speculate that Fto’s effect on TH, may be relevant to
the energy expenditure phenotype seen in Fto null mice by acting
on the norepinephrein pathways or on the dopaminergic reward
pathways for effects on food intake. However, the physiological
relevance of these findings require further exploration.
In conclusion, our findings provide further support for the
notion that FTO itself can influence key components of energy
balance, most likely acting through central action on appetite, and
is therefore a strong candidate for the mediation of the robust
association between FTO intronic variants and adiposity. Impor-
tantly they provide the first indication that selective alteration of
Fto levels in the hypothalamus can influence food intake, a finding
consistent with the reported effects of FTO alleles on appetite and
food intake in man.
Materials and Methods
Ethics Statement
All animal procedures were carried out in strict accordance with
regulations and guidelines of the United Kingdom Home Office.
Animals
Adult male Wister rats (250–300g, Charles River) were single
housed throughout the study. All rats were maintained under
controlled temperature (22uC) and on a 12-h light, 12-h dark
schedule (lights on 7:00–19:00). Standard chow (Special Diet
Services, SDS) and water were available ad libitum. For the high fat
Figure 4. Effects of AAV-shRNA and AAV-Fto microinjection in hypothalamic PVN. Effects of manipulating Fto expression in rat
hypothalamic PVN. PVN injection of AAV-Fto reduces (A) daily (F1,130 = 7.986; p = 0.01) and (B) cumulative (F1,130 = 10.70; p = 0.006) food intake while
(C) AAV-shRNA has no impact. (D) Food reducing effects of Fto over expression in the PVN was significant for 2 weeks. All values are expressed as
mean 6S.E.M. Statistical comparison between control and treated groups for each site were performed by two-tailed unpaired Student’s t-test.
*p,0.05; **p,0.01. For the analysis of food intake over time, two-way repeated measure ANOVA was used with time and treatment as variables for
comparison.
doi:10.1371/journal.pone.0008771.g004
Figure 5. Effects of manipulating ARC Fto on genes involved in
energy homeostasis. Bar graphs show no change of Agrp, Npy and
Pomc expression in response to arcuate injection of AAV-Fto or AAV-
shRNA, while TH expression in the ARC decreases by 5- fold and Stat3
expression increases by 4-fold in response to Fto overexpression.
Response of each gene was measured 3 weeks following intra-ARC
injection, data normalized to B-actin and expressed in terms of fold
induction over its expression in controls. P-value was calculated using a
two-tailed distribution unpaired Student’s t-test. Data is represented as
the mean 6S.E.M of at least 6 independent rats per group; *p,0.05.
doi:10.1371/journal.pone.0008771.g005
Hypothalamic Fto
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diet study, groups of male Wister around 200g were put on a 45%
fat diet (D12451, SDS) for 10 weeks. Prior to all procedures
animals were allowed to acclimatise for at least one week.
Design and Construction of AAV Vectors
Six pairs of oligos of 19 nucleotides within the Fto coding region
of the rat were designed using Ambion software and the efficacy of
these sequences in knocking down the Fto transcript was tested in
cultured GT1-7 cells. The two most effective pair of sequences
were cloned into a hairpin structure. Briefly, the olionucleotide,
containing either one of these 19 nucleotide sequences, separated
by a short spacer from the reverse complement of the same
sequence and a five thymidine termination signal, was cloned into
the pSilencer expression vector system (Ambion) downstream of an
U6 RNA polymerase III promoter. The U6 promoter, Fto hairpin
sequence and terminator sequences were subcloned into the
multicloning site of the pAAV-MCS backbone (Stratagene) to
generate the corresponding AAV-shRNA vectors. An AAV vector
expressing a scrambled shRNA sequence was used as a control for
the knock-down study. To generate Fto expressing AAV vectors,
the cDNA of murine Fto was cloned into an AAV backbone
plasmid under the control of the ubiquitous hybrid promoter CAG
that contains the chicken ß-actin promoter and CMV enhancer.
Empty AAV vectors expressing no proteins were used as a control
for the overexpression study. AAV-GFP was also produced to
initially test for optimum serotype and titre, as well as accuracy of
intranuclear injections.
Viral Production and Purification
Vectors were generated by helper virus-free transfection of
HEK293 cells using three plasmids [21] with modifications [22].
Cells were cultured to 70% confluence in roller bottles (RB)
(Corning) in DMEM supplemented with 10% FBS and then co-
transfected with: 1) a plasmid carrying the expression cassette
flanked by the viral ITRs (described above); 2) a helper plasmid
carrying the AAV rep and cap genes; and 3) a plasmid carrying the
adenovirus helper functions. In this study we initially used
plasmids carrying serotype 5,7,8,9 cap genes to generate AAV-
2/5,2/7,2/8, and 2/9-GFPs to obtain optimal viral infection for
the hypothalamic nuclei. GFP immunohistochemistry was per-
formed 7 days after injections. AAV-2/7 seemed best for the
hypothalamus, thus all the experimental virus were generate using
serotype 7 cap genes. Plasmids carrying the adenovirus helper
functions and cap genes were kindly provided by K.A. High,
Children’s Hospital of Philadelphia. Vectors were purified by two
consecutives cesium chloride gradients using an optimized method
[23], dialyzed against PBS, filtered, titred by qPCR and stored at
280uC until use.
Stereotactic Surgery
Weight-matched rats were anesthetized with 40mg/kg ketamine
and 20mg/kg xylazine, injected intramuscularly. Under anesthe-
sia, a temporary 31 gauge needle (Hamilton) was inserted into the
ARC or PVN according to the stereotactic coordinates of Paxinos
and Watson [24]. The stereotactic coordinates for injection into
the ARC were 2.8mm caudal to bregma, 0.4mm lateral to the
midline and 10mm below the surface of the skull; for PVN 1.8mm
caudal to bregma, 0.5mm lateral to the midline and 8mm below
the surface of the skull. With a 10ul Hamilton micro-syringe, 1ul of
261012vg/ml vector preparations were injected into the nuclei
over a 10min period. After vector delivery, the needle was left in
place for 5 min to prevent reflux. Food intake and body weight
were measured daily for two weeks following AAV microinjection,
and were analyzed beginning on day 4 to allow time for
postoperative recovery and for adenoviral gene to be expressed.
At the end of the study, 3 weeks after AAV injection, whole brains
were rapidly isolated and frozen on dry ice. Mesenteric and
retroperitoneal fat pads were also dissected and weighted to the
nearest 2 decimal place.
Histological Analysis
For double-labelling of tissue sections with both isotopic and
non-isotopic cRNA probes, a modification of our previously
described protocol to detect Fto expression [16] was employed.
Briefly, brains were sliced at 14um thickness and mounted on
poly-L-lysine-coated slides (Fisher Scientific), dried overnight and
then stored at 280uC. Slides were fixed in 4% paraformaldehyde
followed by a microwave pretreatment with 10mM sodium citrate
buffer, pH6.0 and dehydrated using a graded concentrations of
ethanol (50–100%). 35S-labelled Fto cRNA was prepared as
previously described [16], in addition, as a counterprobe, a
digoxigenin (DIG)-labelled Pomc cRNA probe was prepared. Dig-
labelled probes for sense and antisense Pomc mRNA were
generated from the cDNA template corresponding to exon3 of
Pomc in a pGem- T vector (Promega) and transcribed by SP6 or
T7 RNA polymerase (Progema). 35S-labeled Fto probes and DIG-
labelled Pomc probes were synthesized in parallel with either 35S-
labeled UTP (GE Healthcare) or DIG-labelling mixture contain-
ing 10 mM ATP, CTP, GTP; 6.5 mM UTP; 3.5 mM DIG-
labelled UTP (Boehringer Mannheim). Both probes were added to
the hybridization buffer at the same concentration and sections
were hybridized overnight at 57uC. After hybridization, slides
were RNase treated followed by immunohistochemical detection
of DIG. This was achieved by incubation of the brain section in
blocking buffer containing 1:500 dilution of AP conjugated anti-
DIG antibody (Boehringer Mannheim) follow by the incubation in
the detection buffer containing NBT, BCIP and levamisole. Slides
were then covered with K5D emulsion (Ilford) and exposed for at
least 2 weeks for the detection of 35S signal. Cells were considered
positive for a message (for either DIG or 35S) if the signal was at
least twice the background level. To assess differential sensitivity
between isotopic and non-isotopic probes, the experiment was run
with reversed labelled probe (i.e. Fto cRNA labelled with DIG and
Pomc labelled with 35S).
To validate injection site and to establish a time course of
protein expression for AAV2/7 serotype, at 3, 7 and 60 days after
AAV-GFP injection, rats were anesthetized and perfused with 4%
paraformaldehyde. Brains were fixed with 4% paraformaldehyde
by transcardial perfusion and processed to produce 35um coronal
cryostat sections. Successful injection and optimal virus titer were
determined by the presence of GFP producing cells in the ARC
and the PVN.
RT-PCR
Micro-punches of ARC and PVN from individual rats were
obtained based on the method originally described by Palkovits
[25] with the shape of the basal hypothalamus, the ventricles and
the major tracts serving as landmarks for localization during the
process of removal. Accuracy of the micro-punches was confirmed
with cresyl violet staining on the cryostat sections after nuclei
removal. RNA was isolated from the micro-punch using the
PARISTM system (Ambion) and 200ng of purified RNA were used
in a random-primed first strand cDNA synthesis reaction, using
Superscript III reverse transcriptase (Invitrogen). Quantitative
PCR reactions for Fto were performed in triplicate on an ABI
7900HT (Applied Biosystems) and using ABI PCR master mix,
according to manufacturer’s protocols. Arcuate expression of Agrp,
Pomc and Npy was also quantified by real time PCR in these same
Hypothalamic Fto
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samples, but the RNA had to be amplified before being used as
template. Briefly, 5ng total RNA was DNase treated (TURBO
DNaseTM, Ambion) and subjected to the WT-OVATIONTM Pico
RNA Amplification System (NuGen Technologies, Inc) according
to manufacturer’s instructions. For the real time quantitative PCR
data, all statistics were done on delta Ct values normalized to B-
actin and expressed as ratio of control.
Western Blot Analysis
Lysates for western blots were prepared using the PARISTM kit
with a protease inhibitor cocktail (Sigma). Western blots were
probed with mouse monoclonal antibodies directed against the C-
terminal FTO (1:500; Abcam). B-actin (1:1000; Abcam) was used
as a loading control. Bands were visualized and semi-quantified
using Chemoluminescence (Syngene).
Statistical Analysis
All values are expressed as mean 6S.E.M. For each variable,
statistical comparison between control and treated groups for each
site were performed by two-tailed unpaired Student’s t-test. For
the analysis of food intake and body weight over time, two-way
repeated measures ANOVA was used with time and treatment as
variables for comparison. Statistical analysis was performed using
Graph Pad Prism software (GraphPad Prism).
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